![C45H56N7O9P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-methyl- N-(2-methyl-1-oxopropyl)-, 3′ – [2-cyanoethyl N,N-bis(1-methylethyl) phosphoramidite] (ACI)](http://cdn.globalso.com/nvchem/style/global/img/demo/page_banner.jpg)
![C45H56N7O9p guanosine, 5 ′ -O- [bis (4-methoxyphenyl) fenilmetil] -2 ′ -O-methyl- N- (2-methyl-1-oxopropyl)-, 3 ′-2-cyanoethyl N, N-bis (1-Methyhy)](https://cdn.globalso.com/nvchem/C45H56N7O9P.png)
C45H56N7O9P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-methyl- N-(2-methyl-1-oxopropyl)-, 3′ – [2-cyanoethyl N,N-bis(1-methylethyl) phosphoramidite] (ACI)
Nimewo rejis CAS
150780-67-9
H303
| Kle pwopriyete fizik | Valè | Kondisyon |
| Pwa molekilè | 869.94 | - |
| PKA (prevwa) | 9.16 ± 0.20 | Pifò asid tanperati: 25 ° C |
N#CCCOP (OC1C (OC (N2C = NC = 3C (= O) N = C (NC (= O) C (C) C) NC32) C1OC) COC (C = 4C = CC = CC4) (C5 = CC = C (OC) C = C5) C6 = C = C (OC
Souri izomèr
C (oc [c @@ h] 1 [c @@ h] (op (n (c (c) c) c (c) c) occc#n) [c @@ h] (oc) [c @@ h] (o1) n2c3 = c (n = c2) c (= o) n = c (nc (c (c) c) = o) n3) (c = c = c (n (c (c) c) = o) n3) C = c4) (c5 = cc = c (oc) c = c5) c6 = cc = cc = c6
Inchi
Inchi = 1S/C45H56N7O9P/C1-28 (2) 41 (53) 49-44-48-40-37 (42 (54) 50-44) 47-27-51 (40) 43-39 (57-9) 38 (61-62 (59-25-10-9-9)
46) 52 (29 (3) 4) 30 (5) 6) 36 (6. -30,36,38-39,43h, 13,25-26h2,1-9h3, (H2,48,49,50,53,54)/T36-, 38-, 39-, 43-, 62?/M1/S1
Inchi kle
Irrdhrzuoznwdj-mlldkzsosa-n
1 lòt non pou sibstans sa a
Guanosine, 5 ′ -O-[bis (4-metoxyphenyl) fenilmetil] -2 ′-O-metil-N-(2-methyl-1-oxopropyl)-, 3 ′-[2-cyanoethyl bis (1-methylethyl) fosforamidit] (9CI)
Spèktr ki disponib
13 C NMR
Etero nmr
Pwopriyete ki disponib
Biolojik
Chimik
Lipinski
Estrikti ki gen rapò
| Posesyon | Valè | Kondisyon | Sous |
| Faktè bioconcentration | 183 | Ph 1; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 3890 | pH 2; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 35500 | pH 3; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 1.08 x 105 | pH 4; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 1.36 x 105 | pH 5; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 1.39 x 105 | pH 6; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 1.38 x 105 | pH 7; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 1.24 x 105 | pH 8; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 63600 | pH 9; Tan: 25 ° C | (1) ACD |
| Faktè bioconcentration | 11900 | pH 10; Tan: 25 ° C | (1) ACD |
(1) Kalkile lè l sèvi avèk avanse Chimi Devlopman (ACD/Labs) lojisyèl v11.02 (© 1994-2023 ACD/Labs)
| Posesyon | Valè | Kondisyon | Sous |
| Ka | 220 | Ph 1; Tan: 25 ° C | (1) ACD |
| Ka | 4680 | pH 2; Tan: 25 ° C | (1) ACD |
| Ka | 42600 | pH 3; Tan: 25 ° C | (1) ACD |
| Ka | 1.30 x 105 | pH 4; Tan: 25 ° C | (1) ACD |
| Ka | 1.63 x 105 | pH 5; Tan: 25 ° C | (1) ACD |
| Ka | 1.67 x 105 | pH 6; Tan: 25 ° C | (1) ACD |
| Ka | 1.65 x 105 | pH 7; Tan: 25 ° C | (1) ACD |
| Ka | 1.49 x 105 | pH 8; Tan: 25 ° C | (1) ACD |
| Posesyon | Valè | Kondisyon | Sous |
| Ka | 76400 | pH 9; Tan: 25 ° C | (1) ACD |
| Ka | 14200 | pH 10; Tan: 25 ° C | (1) ACD |
| Logd | 4.19 | Ph 1; Tan: 25 ° C | (1) ACD |
| Logd | 5.52 | pH 2; Tan: 25 ° C | (1) ACD |
| Logd | 6.48 | pH 3; Tan: 25 ° C | (1) ACD |
| Logd | 6.96 | pH 4; Tan: 25 ° C | (1) ACD |
| Logd | 7.06 | pH 5; Tan: 25 ° C | (1) ACD |
| Logd | 7.07 | pH 6; Tan: 25 ° C | (1) ACD |
| Logd | 7.07 | pH 7; Tan: 25 ° C | (1) ACD |
| Logd | 7.02 | pH 8; Tan: 25 ° C | (1) ACD |
| Logd | 6.73 | pH 9; Tan: 25 ° C | (1) ACD |
| Logd | 6.00 | pH 10; Tan: 25 ° C | (1) ACD |
| logp | 7.072 ± 0.721 | Tan: 25 ° C | (1) ACD |
| Mas solubilite intrinsèques | 1.2 x 10-4 g/l | Tan: 25 ° C | (1) ACD |
| Mas solubility | 0.096 g/l | Ph 1; Tan: 25 ° C | (1) ACD |
| Mas solubility | 4.3 x 10-3 g/l | pH 2; Tan: 25 ° C | (1) ACD |
| Mas solubility | 4.8 x 10-4 g/l | pH 3; Tan: 25 ° C | (1) ACD |
| Mas solubility | 1.6 x 10-4 g/l | pH 4; Tan: 25 ° C | (1) ACD |
| Mas solubility | 1.2 x 10-4 g/l | pH 5; Tan: 25 ° C | (1) ACD |
| Mas solubility | 1.2 x 10-4 g/l | pH 6; Tan: 25 ° C | (1) ACD |
| Mas solubility | 1.2 x 10-4 g/l | pH 7; Tan: 25 ° C | (1) ACD |
| Mas solubility | 1.4 x 10-4 g/l | pH 8; Tan: 25 ° C | (1) ACD |
| Mas solubility | 2.7 x 10-4 g/l | pH 9; Tan: 25 ° C | (1) ACD |
| Mas solubility | 1.4 x 10-3 g/l | pH 10; Tan: 25 ° C | (1) ACD |
| Mas solubility | 1.2 x 10-4 g/l | PH dlo unbuffered 7.00; Tan: 25 ° C | (1) ACD |
| Molar intrinsèques solubility | 1.4 x 10-7 mol/l | Tan: 25 ° C | (1) ACD |
| Solubilite molè | 1.1 x 10-4 mol/l | Ph 1; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 5.0 x 10-6 mol/l | pH 2; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 5.5 x 10-7 mol/l | pH 3; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 1.8 x 10-7 mol/l | pH 4; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 1.4 x 10-7 mol/l | pH 5; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 1.4 x 10-7 mol/l | pH 6; Tan: 25 ° C | (1) ACD |
| Posesyon | Valè | Kondisyon | Sous |
| Solubilite molè | 1.4 x 10-7 mol/l | pH 7; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 1.6 x 10-7 mol/l | pH 8; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 3.1 x 10-7 mol/l | pH 9; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 1.6 x 10-6 mol/l | pH 10; Tan: 25 ° C | (1) ACD |
| Solubilite molè | 1.4 x 10-7 mol/l | PH dlo unbuffered 7.00; Tan: 25 ° C | (1) ACD |
| Pwa molekilè | 869.94 | ||
| pka | 9.16 ± 0.20 | Pifò asid tanperati: 25 ° C | (1) ACD |
| pka | 3.45 ± 0.70 | Pifò debaz tanperati: 25 ° C | (1) ACD |
(1) Kalkile lè l sèvi avèk avanse Chimi Devlopman (ACD/Labs) lojisyèl v11.02 (© 1994-2023 ACD/Labs)
| Posesyon | Valè | Kondisyon | Sous |
| Lib lib wotasyon | 19 | (1) ACD | |
| H akseptab | 16 | (1) ACD | |
| H donatè | 2 | (1) ACD | |
| H donatè/aksepte sòm | 18 | (1) ACD | |
| logp | 7.072 ± 0.721 | Tan: 25 ° C | (1) ACD |
| Pwa molekilè | 869.94 |
(1) Kalkile lè l sèvi avèk avanse Chimi Devlopman (ACD/Labs) lojisyèl v11.02 (© 1994-2023 ACD/Labs)
| Posesyon | Valè | Sous kondisyon |
| Zòn sifas polè | 194 A2 | (1) ACD |
(1) Kalkile lè l sèvi avèk avanse Chimi Devlopman (ACD/Labs) lojisyèl v11.02 (© 1994-2023 ACD/Labs)
Spèktr ki disponib
1 H NMR
13 C NMR
| Kòd | Deklarasyon danje | Sous |
| H303 | Ka danjere si vale | Ekspè òganize |
![C39h46fn4o8p uridine, 5 ′ -o- [bis (4-methoxyphenyl) phenylmethyl] -2 ′ -deoxy-2 ′-fluoro-, 3 ′-[2-cyanoethyl N, N-bis (1-methylethyl) Phosphoramid] n, N-bis (1-methylethyl) fosphoramid], N-bis (1-methylethyl) fosphoramid], N-bis (1-methylethyl) fosphoramid.](https://cdn.globalso.com/nvchem/C39H46FN4O8P-Uridine-300x300.png)
![C21H21N3O6 timidin, α- [(1-naphtalenylmethyl) amino]- α-OXO- (ACI)](https://cdn.globalso.com/nvchem/C21H21N3O6-Thymidine-300x300.png)
![118 Re36H44N2O8SI Uridine, 5′-O- [bis (4-methoxyphenyl) phenylmethyl] -2′-O-[(1,1- dimethylethyl) dimethylsilyl]-(9ci, ACI)](https://cdn.globalso.com/nvchem/118-Re36H44N2O8Si-Uridine-300x300.jpg)
![C13H13NO5 1H-Pyrano [3,4-F] indolizine-3,6,10 (4H) -Tione, 4-ethyl-7,8-dihydro-4- hydroxy-, (4s)-(9ci, ACI) H319, H302](https://cdn.globalso.com/nvchem/C13H13NO5-1H-Pyrano-300x300.jpg)
![C47H60N7O10P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-(2- methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′ – [2-cyanoethyl N,N-bis (1-methylethyl)phosphoramidite] (ACI)](https://cdn.globalso.com/nvchem/C47H60N7O10P-Guanosine-300x300.png)